ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO2307

ESRD Risk in Type 1 vs. Type 2 Childhood-Onset Diabetes Mellitus

Session Information

Category: Pediatric Nephrology

  • 1700 Pediatric Nephrology


  • Pleniceanu, Oren, Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
  • Twig, Gilad, Israel Defense Forces, Tel Aviv, Tel Aviv, Israel
  • Erlich, Tomer, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel
  • Keinan Boker, Lital, University of Haifa School of Public Health, Haifa, Haifa, Israel
  • Skorecki, Karl, Rambam Health Care Campus, Haifa, Haifa, Israel
  • Calderon-margalit, Ronit, Hebrew University of Jerusalem Braun School of Public Health and Community Medicine, Jerusalem, Jerusalem, Israel
  • Vivante, Asaf, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel

Diabetic kidney disease (DKD) is becoming increasingly common among children. We aimed to estimate the risk of end-stage renal disease (ESRD) and mortality among adolescents with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) and normal renal function compared to non-diabetics. We hypothesized that childhood onset T1DM vs T2DM would be associated with a different risk profile for developing ESRD and its complications.


A nationwide, population-based, retrospective cohort study, including 1,500,522 adolescents examined for military service between 1967-1997, which were classified according to the presence and type of diabetes. Data were linked to the Israeli ESRD registry. Cox proportional-hazards models were used to estimate the hazard ratio (HR) for ESRD.


At study enrolment, 1,183 adolescents had T1DM and 196 had T2DM. ESRD developed in 2,386 non-diabetic individuals (0.2%) compared to 72 individuals (6.1%) with T1DM, and 8 individuals (4.1%) with T2DM. Participants with T1DM were younger at ESRD onset than participants with T2DM (median age: 36.0 vs. 40.5 years, P<0.05). In a multivariate model adjusted for age, sex, paternal origin, enrollment year, BMI, and blood pressure, T1DM and T2DM were associated with HR of 36.4 (95% CI, 28.3-46.9) and 19.3 (95%CI, 9.6-38.8) for ESRD, respectively. Stratification according to sex, ethnicity, immigration and socioeconomic status did not materially change the HR. During the follow-up period, mortality rates were higher in T2DM as compared to T1DM and controls (8.7 %, 2.2% and 2.7% respectively).


T1DM and T2DM in adolescents with normal renal function confer a significantly increased risk for ESRD. T1DM is associated with younger age at ESRD onset while T2DM is associated with higher mortality rate.

Cumulative ESRD incidence